Sovereigndebt worries and continued market volatility in Europe have discouraged bankershopes for a pick-up in dealmaking. By now $262.4bn-worth of deals has beenannounced –a 4.4 per cent decrease compared to same period last year, accordingto Dealogic.
In the firsthalf of 2010 deal volumes have been incited as a result of some M&Aactivity in the consumer and healthcare sectors. Some of those are the $6bntakeover of Millipore, the US laboratory supplies maker by the German drug andchemical group Merck's and the decision by Grifols, Europe's largest maker ofblood-plasma products, to acquire US-listed rival Talecris Biotherapeutics forcash and stock.
Nobel Advisers has one of the most experienced teams on the Bulgarian market. The team has executed more than 50 deals in the last 15 years with a volume of over EUR 1.5 billion. The team has handled leading regional and international corporate clients, private equity houses, and strategic investors. See more
Management Advisory 
Mergers & Acquisitions
Corporate Restructuring 
Financial Consulting 
Risk Management
Other